A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of ASP3291 Following a Single Oral Dose in Subjects With Mild to Moderately Active Ulcerative Colitis.

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of ASP3291 Following a Single Oral Dose in Subjects With Mild to Moderately Active Ulcerative Colitis.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Jul 2012

At a glance

  • Drugs ASP 3291 (Primary)
  • Indications Ulcerative colitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Aug 2011 Actual end date Aug 2011 added as reported by ClinicalTrials.gov.
    • 26 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top